DexCom Inc (DXCM)
NASDAQ · Healthcare · Medical Devices
DexCom Inc is a Healthcare company with a market capitalization of $33.38B and a trailing P/E ratio of 35.0.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $0.56 | $0.47 | +19.1% |
| Q4 2025 | February 12, 2026 | $0.68 | $0.65 | +4.6% |
| Q3 2025 | October 30, 2025 | $0.61 | $0.57 | +7.0% |
| Q2 2025 | July 30, 2025 | $0.48 | $0.44 | +9.1% |
| Q1 2025 | May 1, 2025 | $0.32 | $0.33 | -3.0% |
| Q4 2024 | February 13, 2025 | $0.45 | $0.50 | -10.0% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 18,654,724 | 4.74% | 4.4 | +3.0% |
| June 30, 2026 | 18,109,268 | 4.60% | 3.6 | +6.4% |
| June 15, 2026 | 17,017,820 | 4.32% | 3.2 | -2.2% |
| May 29, 2026 | 17,394,929 | 4.42% | 2.1 | -1.0% |
| May 15, 2026 | 17,564,139 | 4.46% | 2.8 | -4.1% |
| April 30, 2026 | 18,320,577 | 4.65% | 4.0 | +20.6% |
| April 15, 2026 | 15,190,268 | 3.81% | 4.1 | +3.2% |
| March 31, 2026 | 14,716,509 | 3.69% | 3.5 | -9.7% |
Other Medical Devices Stocks
Frequently Asked Questions
What is DexCom Inc's market cap?
As of August 13, 2026, DexCom Inc (DXCM) has a market capitalization of $33.38B.
What is DexCom Inc's P/E ratio?
DexCom Inc trades at a trailing price-to-earnings (P/E) ratio of 35.0. Its forward P/E is 34.9.
Does DexCom Inc pay a dividend?
DexCom Inc does not currently pay a dividend.
What sector is DXCM in?
DexCom Inc is in the Healthcare sector, specifically the Medical Devices industry.
What is DexCom Inc's short interest?
As of the July 15, 2026 FINRA settlement, 18,654,724 DXCM shares were sold short, or 4.74% of shares outstanding. Days to cover: 4.4. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was DexCom Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), DexCom Inc reported revenue of $4.66B and net income of $836.30M.
Ask your own questions about DXCM
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.